MedTrace Logo

Evaluation of Fertitonex Effects on Semen Parameters in Clinical Varicocele Patient.

NCT06718426 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2025-03-26

No results posted yet for this study

Summary

The aim of the study is to evaluate the Fertitonex effects on semen parameters in clinical varicocele patients.

Conditions

  • Varicocele

Interventions

DRUG

Fertitonex capsule

Fertitonex which contains L- carnitine L-tartarate 300 mg, L-arginine 241mg, vitamin B6 1.1 mg, vitamin B12 1.7 mcg, vitamin D3 2 mcg, vitamin E 6.5 mg, vitamin C 60 mg, selenium 28 mcg, zinc 7.5 mg, folic acid 300 mcg and CoQ 10 enzyme 7.5 mg in each capsule. The dose will be one capsule twice daily for 3 months.

DRUG

Placebo Oral Capsule

placebo oral capsule. the dose is twice daily for 3 months

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2025-11-30
Completion
2026-02-01

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06718426 on ClinicalTrials.gov